Nuclivision attends the RSNA Annual Meeting in Chicago

The annual meeting of RSNA places the power of medical imaging AI "right at your fingertips" by providing a large platform for AI focused companies, research and applications in clinical practice. Our CEO - Maarten Larmuseau - will be attending the conference exploring the latest insights and present the latest data on low count PET imaging with NUCLARITY both during an oral and poster presentation.

During the poster session on December 2nd, results from a multicenter, multi-tracer study showing how Nuclarity improves low-count PET images — enabling shorter scan times and lower doses. The poster, titled "Low-count whole-body PET with deep learning in a multicenter, multi-tracer and externally validated study", underscored the robustness of the algorithm across clinical sites and tracers.

A dedicated talk will be provided exploring the question whether AI based denoising can replace 18F-FDG in early perfusionamloid PET imaging. The presented research shows that early perfusion imaging with 3-min scans, enhanced by NUCLARITY®, has the potential to provide clinically relevant information comparable to [F-18]-FDG — paving the way for faster, less invasive, and more efficient neurodegenerative PET diagnostics.

This meeting also provides excellent opportunity to connect with major industry players and fellow start-ups; as well as renewed researchers in the field that are pushing the boundaries of medical imaging. Looking forward to connect and engage with everyone at RSNA 2025!

‍